By Antoinette Kraus Prescription drug pricing is reaching a crisis point. A 2018 study showed that between 2012 and 2017, the cost of prescription drugs under Medicare increased nearly 10 times faster than the rate of inflation. And it continues to rise; the prices of more than 400 prescription drugs have already increased by an […]
By Faisal Chaudhry The high price of insulin, which has reached as much as US$450 per month, has raised outrage across the country. Sen. Bernie Sanders (I-Vt.) has called it a national embarrassment, wondering why U.S. residents should have to drive to Canada to buy cheaper insulin. As a legal scholar who focuses on the […]
By Oliver McPherson-Smith and Steve Pociask Soaring prescription drug prices are putting financial pressure on families across the country. In response, state legislators are increasingly considering limits on the annual price increase of prescription drugs. But rather than making drugs more affordable, these policies risk reducing consumer access to cheaper, generic alternatives. In an effort […]
By Margarida Jorge and Frank Clemente Last week’s House vote to rein in skyrocketing prescription drug prices was overdue. Now it’s up to the Senate and President Donald Trump to take action. Working families and seniors are struggling to pay for the high cost of often life-saving medicines, and have been for years. But price […]
By Kathy Sheran It’s been a while since I put my oar in the water on public policy, but there is an important issue that needs a lot of attention from all of us. When the cost of health care keeps growing, but our income stays flat, health care eats up more and more of […]
By Thomas Sullivan At the recent Milken Institute’s Future of Health Summit in Washington, DC, Centers for Medicare and Medicaid Services (“CMS”) Administrator Seema Verma spoke about new drug launch prices and posed the question “What is too high?” As reported by FierceHealthcare, Verma discussed Sovaldi, Gilead Sciences’ Hepatitis C cure, that launched at nearly […]
By Jessie Hellmann Prescription drug companies and trade groups shelled out millions of dollars to lobby Congress as it considered legislation aimed at reining in skyrocketing drug prices, according to new lobbying disclosure reports. The Pharmaceutical Research and Manufacturers of America (PhRMA) — the trade group representing branded drug companies — spent $6.2 million on […]
The American patent system has, since our nation’s founding, served as a cornerstone of innovation.
Lobbying organizations, companies—and individuals—can and do donate money to political campaigns.
Prices for the majority of drugs in the U.S. have started to rise more slowly, likely a result of public and political pressure.